Home › Funds › Artia Global Partners LP › TRVI

Artia Global Partners LP position in TRVI

TREVI THERAPEUTICS INC COM · Health Care

Artia Global Partners LP reported holding 2,210,852 shares of TRVI (TREVI THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$41.2M, representing 7.61% of its reported portfolio and ranking #3 among its reported holdings. Artia Global Partners LP has disclosed TRVI holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)2.21M sh
Reported value held$41.23M
Portfolio Weight7.61%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's TRVI position evolved

Artia Global Partners LP first disclosed a stake in TRVI in Q2 2025 at 1,311,840 shares (US$7.2M). The position peaked in Q2 2026 at 2,210,852 shares, worth US$41.2M. Across 5 filings, Artia Global Partners LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 2,210,852 shares valued at US$41.2M — an increase of 197,250 shares quarter over quarter.. Notable position changes include a 52% increase in Q3 2025 (shares rose 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 1.31M $7.18M New
Q3 2025 2.00M $18.30M Add
Q4 2025 2.01M $25.21M Add
Q1 2026 2.01M $24.02M Hold
Q2 2026 2.21M $41.23M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC COM) is a Health Care company. 64 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$95.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has Artia Global Partners LP held TRVI?

Artia Global Partners LP has disclosed TRVI holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Artia Global Partners LP's current position in TRVI?

As of Q2 2026, Artia Global Partners LP holds 2.21M shares of TRVI (TREVI THERAPEUTICS INC COM), valued at $41.23M, representing 7.61% of its reported portfolio and ranking #3.

Has Artia Global Partners LP been buying or selling TRVI?

In the latest 13F filing (Q2 2026), Artia Global Partners LP increased its position in TRVI. The position peaked in Q2 2026 at 2.21M shares.

Which other funds hold TRVI?

Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.